Skip to main content
Keeping you afloat amidst the rising sea of regulations

New CMS System to Report Average Sales Price (ASP) Data for Part B Drugs

A long time coming and after much anticipation and speculation, CMS is about to unveil an electronic reporting system in which manufacturers will report to CMS their quarterly ASP calculations. Manufacturers must begin to use this system to report ASPs for their Medicare Part B eligible drug products beginning with the Q2 2018 reporting, due April 30, 2018. For Q2 2018 only, the data also must be sent using the current manual process, which will be replaced by the electronic system permanently beginning with the Q3 2018 ASP submission. CMS is holding a call to explain the new system on Tuesday, March 27, 2-3pm ET.

To register for this MLN Connects call, click here.

The Arent Fox Health Care Group has been actively monitoring CMS’s changes to the ASP reporting system. If you have any questions about this topic, please contact Stephanie Trunk or Erin Atkins in our Washington, DC office, or the Arent Fox professional who regularly handles your matters.